Oncogenes, antioncogenes, and the regulation of cell growth

M Carbone1, A S Levine

  • 1Section on Viruses and Cellular Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

Proto-oncogenes are normal genes crucial for cell growth and differentiation. Mutations can cause these proto-oncogenes to become oncogenes, leading to uncontrolled cell proliferation and cancer development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Biology

Background:

  • Proto-oncogenes are integral to normal cellular functions, including proliferation and differentiation.
  • These genes exhibit tissue-specific and developmental-specific expression patterns in healthy cells.
  • Aberrant expression or mutations can transform proto-oncogenes into oncogenes, driving cancer formation.

Purpose of the Study:

  • To elucidate the role of proto-oncogenes in normal cell growth and cancer.
  • To understand the molecular mechanisms underlying oncogene activation and its impact on cell signaling.
  • To explore the contribution of oncogenes and suppressor genes to the regulation of cell proliferation.

Main Methods:

  • Analysis of proto-oncogene expression in various cell types and developmental stages.
  • Investigation of mutations leading to oncogene activation.
  • Study of signal transduction pathways affected by oncogenic proteins.
  • Examination of the interplay between oncogenes and tumor suppressor genes (antioncogenes).

Main Results:

  • Proto-oncogenes possess normal physiological roles in cell growth and differentiation.
  • Mutations can lead to inappropriate expression or constitutive activation of oncogenic proteins.
  • Activated oncogenes promote tumor growth by overriding normal growth regulatory signals.
  • Oncogenes and suppressor genes are key regulators of cell proliferation signals.

Conclusions:

  • Understanding oncogene activation is critical for comprehending cancer development.
  • Molecular mechanisms of oncogenes provide insights into the regulation of normal cell growth.
  • Targeting oncogenic pathways offers potential therapeutic strategies for cancer treatment.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...